These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 16793756)

  • 1. Membrane lipid fluidity of blood platelets: a common denominator that underlies the opposing actions of various agents that affect platelet activation in whole blood.
    Watala C; Golański J; Boncler MA; Pietrucha T; Gwoździński K
    Platelets; 1998; 9(5):315-27. PubMed ID: 16793756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes mellitus alters the effect of peptide and protein ligands on membrane fluidity of blood platelets.
    Watala C; Gwoździński K; Pluskota E; Pietrucha T; Walkowiak B; Trojanowski Z; Cierniewski CS
    Thromb Haemost; 1996 Jan; 75(1):147-53. PubMed ID: 8713794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Release of calcium and P-selectin from intraplatelet granules is hampered by procaine.
    Watala C; Boncler M; Golański J; Koziołkiewicz W; Walkowiak B; Cierniewski CS
    Thromb Res; 1999 Apr; 94(1):1-11. PubMed ID: 10213176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response of human blood platelet membrane to sodium selenite.
    Zbikowska HM; Gwoździński K; Wachowicz W; Krajewski T
    J Physiol Pharmacol; 1999 Sep; 50(3):455-62. PubMed ID: 10574474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does reduced membrane lipid fluidity underlie the altered thrombin-induced expression of integrin α(IIb)β(3) and PADGEM-140 in membranes of platelets from diabetic juveniles?
    Watala C; Golański J; Walkowiak B; Baj Z; Pietrucha T; Tchórzewski H; Bodalski J; Ciemiewski CS
    Platelets; 1996; 7(3):173-80. PubMed ID: 21043597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microenvironment changes in human blood platelet membranes associated with binding of tissue-type plasminogen activator.
    Watala C; Pietrucha T; Gwozdzinski K; Kralisz U; Cierniewski CS
    Eur J Biochem; 1993 Aug; 215(3):867-71. PubMed ID: 8394814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible mechanisms of the altered platelet volume distribution in type 2 diabetes: does increased platelet activation contribute to platelet size heterogeneity?
    Watala C; Boncler M; Pietrucha T; Trojanowski Z
    Platelets; 1999; 10(1):52-60. PubMed ID: 16801071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulatory effects of Escherichia coli capsular-derived sulfaminoheparosans and heparins on tissue factor-mediated activation of platelets: flow cytometric analysis.
    Maddineni J; Jeske WP; Baltasar F; Cornelli U; Manoni M; Hoppensteadt DA; Fareed J
    Clin Appl Thromb Hemost; 2006 Jul; 12(3):311-7. PubMed ID: 16959684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of green laser light irradiation on whole blood platelets.
    Gresner P; Watała C; Sikurová L
    J Photochem Photobiol B; 2005 Apr; 79(1):43-50. PubMed ID: 15792878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of leukocytes in whole blood samples by N-formyl-methionyl-leucyl-phenylalanine (FMLP) enhances platelet aggregability but not platelet P-selectin exposure and adhesion to leukocytes.
    Lösche W; Redlich H; Krause S; Heptinstall S; Spangenberg P
    Platelets; 1998; 9(3-4):219-21. PubMed ID: 16793705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The S1P(2) receptor expressed in human platelets is linked to the RhoA-Rho kinase pathway and is down regulated in type 2 diabetes.
    Randriamboavonjy V; Badenhoop K; Schmidt H; Geisslinger G; Fisslthaler B; Fleming I
    Basic Res Cardiol; 2009 May; 104(3):333-40. PubMed ID: 19139947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions between lipoproteins and platelet membranes in obesity.
    Raffaelli F; Nanetti L; D'Angelo M; Montecchiani G; Alidori A; Montesi L; Faloia E; Vignini A; Mazzanti L
    Obesity (Silver Spring); 2009 Jul; 17(7):1375-80. PubMed ID: 19197263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reassociation and translocation of glycoprotein IIB-IIIA in EDTA-treated human platelets.
    Ma Y; Wong K
    Platelets; 2007 Sep; 18(6):451-9. PubMed ID: 17763154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do determinants of platelet function co-segregate with genetic markers of type 1 diabetes mellitus?
    Witas HW; Rózalski M; Watała C; Młynarski W; Sychowski R; Bodalski J
    Platelets; 1999; 10(2-3):169-77. PubMed ID: 16801088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased Gs signalling in platelets and impaired collagen activation, due to a defect in the dystrophin gene, result in increased blood loss during spinal surgery.
    Labarque V; Freson K; Thys C; Wittevrongel C; Hoylaerts MF; De Vos R; Goemans N; Van Geet C
    Hum Mol Genet; 2008 Feb; 17(3):357-66. PubMed ID: 17981813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperglycemia-induced alterations in synaptosomal membrane fluidity and activity of membrane bound enzymes: beneficial effect of N-acetylcysteine supplementation.
    Kamboj SS; Chopra K; Sandhir R
    Neuroscience; 2009 Aug; 162(2):349-58. PubMed ID: 19426784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid beta peptide-activated signal pathways in human platelets.
    Shen MY; Hsiao G; Fong TH; Chen HM; Chou DS; Lin CH; Sheu JR; Hsu CY
    Eur J Pharmacol; 2008 Jul; 588(2-3):259-66. PubMed ID: 18511035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vimentin autoantibodies induce platelet activation and formation of platelet-leukocyte conjugates via platelet-activating factor.
    Leong HS; Mahesh BM; Day JR; Smith JD; McCormack AD; Ghimire G; Podor TJ; Rose ML
    J Leukoc Biol; 2008 Feb; 83(2):263-71. PubMed ID: 17974709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelets possess and require an active protein palmitoylation pathway for agonist-mediated activation and in vivo thrombus formation.
    Sim DS; Dilks JR; Flaumenhaft R
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1478-85. PubMed ID: 17303775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of GpIIb/IIIa inhibits the release of vascular endothelial growth factor (VEGF) from tumor cell-activated platelets and experimental metastasis.
    Amirkhosravi A; Amaya M; Siddiqui F; Biggerstaff JP; Meyer TV; Francis JL
    Platelets; 1999; 10(5):285-92. PubMed ID: 16801104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.